2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary

Korean Society of Cardiology (KSC), Korean Academy of Tuberculosis and Respiratory Diseases (KATRD)

Research output: Contribution to journalArticlepeer-review

Abstract

Pulmonary hypertension (PH) is a condition of increased blood pressure in the pulmonary arteries and is diagnosed with an increased a mean pulmonary artery pressure ≥25 mm Hg. This condition may be associated with multiple clinical situations. Based on pathophysiological mechanisms, clinical presentation, hemodynamic profiles, and treatment strategies, the patients were classified into five clinical groups. Although there have been major advances in the management of PH, it is still associated with significant morbidity and mortality. The diagnosis and treatment of PH have been performed mainly by following European guidelines, even in Korea because the country lacks localized PH guidelines. European treatment guidelines do not reflect the actual status of Korea. Therefore, the European diagnosis and treatment of PH have not been tailored well to suit the needs of Korean patients with PH. To address this issue, we developed this guideline to facilitate the diagnosis and treatment of PH appropriately in Korea, a country where the consensus for the diagnosis and treatment of PH remains insufficient. This is the first edition of the guidelines for the diagnosis and treatment of PH in Korea, and it is primarily based on the ‘2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.’ with the acceptance and adaptation of recent publications of PH.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalTuberculosis and Respiratory Diseases
Volume85
Issue number1
DOIs
Publication statusPublished - Jan 2022

Keywords

  • Guidelines
  • Pulmonary Arterial Hypertension
  • Pulmonary Hypertension
  • Treatment

Fingerprint

Dive into the research topics of '2020 KSC/KATRD Guideline for the Diagnosis and Treatment of Pulmonary Hypertension: Executive Summary'. Together they form a unique fingerprint.

Cite this